{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:26:19Z","timestamp":1788981979999,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Government"},{"name":"Andalusian Government"},{"name":"Marcelino Bot\u00edn Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.neurobiolaging.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T07:05:14Z","timestamp":1340780714000},"page":"902-915","source":"Crossref","is-referenced-by-count":31,"title":["Neuroprotective and reparative effects of carotid body grafts in a chronic MPTP model of Parkinson's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Ana B.","family":"Mu\u00f1oz-Manchado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Villadiego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nela","family":"Su\u00e1rez-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Bermejo-Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garrido-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Labandeira-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Barneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Toledo-Aral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.2008.05651.x","article-title":"Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid","volume":"107","author":"Alvarez-Fischer","year":"2008","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0896-6273(95)90024-1","article-title":"GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo","volume":"15","author":"Arenas","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1227\/01.NEU.0000073315.88827.72","article-title":"Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease","volume":"53","author":"Arjona","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2011.05.026","article-title":"Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease","volume":"44","author":"Bartus","year":"2011","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","article-title":"Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor","volume":"19","author":"Batchelor","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2008.04.015","article-title":"Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats","volume":"1217","author":"Belzunegui","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1523\/JNEUROSCI.11-03-00600.1991","article-title":"Distribution of GAP-43 mRNA in the brain stem of adult rats as evidenced by in situ hybridization: localization within monoaminergic neurons","volume":"11","author":"Bendotti","year":"1991","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1523\/JNEUROSCI.08-01-00339.1988","article-title":"Anatomical distribution of the growth-associated protein GAP-43\/B-50 in the adult rat brain","volume":"8","author":"Benowitz","year":"1988","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1474-4422(03)00442-3","article-title":"Neural transplantation for the treatment of Parkinson's disease","volume":"2","author":"Bj\u00f6rklund","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/nbdi.1997.0151","article-title":"Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease","volume":"4","author":"Bj\u00f6rklund","year":"1997","journal-title":"Neurobiol. Dis"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2012.06.001_bib11","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1002\/mds.22785","article-title":"Gene therapy for Parkinson's disease","volume":"25","author":"Bjorklund","year":"2010","journal-title":"Mov. Disord"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.expneurol.2006.06.006","article-title":"A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra","volume":"202","author":"Boger","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrn3039","article-title":"Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates","volume":"12","author":"Collier","year":"2011","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib14","doi-asserted-by":"crossref","first-page":"A32","DOI":"10.1038\/399a032","article-title":"Prospects for new restorative and neuroprotective treatments in Parkinson's disease","volume":"399","author":"Dunnett","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0034-5687(01)00306-1","article-title":"Tissue oxygen tension and brain sensitivity to hypoxia","volume":"128","author":"Ereci\u0144ska","year":"2001","journal-title":"Respir. Physiol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1523\/JNEUROSCI.21-02-00581.2001","article-title":"Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo","volume":"21","author":"Erickson","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0896-6273(00)80449-3","article-title":"Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates","volume":"20","author":"Espejo","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib18","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease","volume":"327","author":"Freed","year":"1992","journal-title":"N Engl J. Med"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib20","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J. Med"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1742-2094-9-38","article-title":"Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease","volume":"9","author":"Garrido-Gil","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2011.02.027","article-title":"Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"180","author":"Goldberg","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","article-title":"The efficiency of systematic sampling in stereology\u2014reconsidered","volume":"193","author":"Gundersen","year":"1999","journal-title":"J. Microsc"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0031-9384(02)00938-1","article-title":"Intrastriatal grafting of glomus cells ameliorates behavioral defects of Parkinsonian rats","volume":"77","author":"Hao","year":"2002","journal-title":"Physiol. Behav"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1523\/JNEUROSCI.2693-11.2012","article-title":"GDNF is predominantly expressed in the PV+ neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway","volume":"32","author":"Hidalgo-Figueroa","year":"2012","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nrneurol.2011.149","article-title":"Parkinson disease: Is GDNF beneficial in Parkinson disease?","volume":"7","author":"Hoffer","year":"2011","journal-title":"Nat. Rev. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jappl.1992.73.1.1","article-title":"Respiratory and circulatory activities in carotid body-resected humans","volume":"73","author":"Honda","year":"1992","journal-title":"J. Appl. Physiol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.resp.2007.12.008","article-title":"Immunohistochemical characterization of the rat carotid body","volume":"161","author":"Izal-Azc\u00e1rate","year":"2008","journal-title":"Respir. Physiol. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib31","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1523\/JNEUROSCI.06-06-01843.1986","article-title":"A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS","volume":"6","author":"Jacobson","year":"1986","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nn1175","article-title":"Localized striatal delivery of GDNF as a treatment for Parkinson disease","volume":"7","author":"Kirik","year":"2004","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2012.06.001_bib34","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.expneurol.2004.08.013","article-title":"Expression and function of GDNF family ligands and receptors in the carotid body","volume":"191","author":"Leitner","year":"2005","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2007.08.019","article-title":"Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?","volume":"209","author":"Lindvall","year":"2008","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0959-4388(03)00093-X","article-title":"Oxygen and glucose sensing by carotid body glomus cells","volume":"13","author":"L\u00f3pez-Barneo","year":"2003","journal-title":"Curr. Opin. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00702-009-0201-5","article-title":"The neurogenic niche in the carotid body and its applicability to antiparkinsonian cell therapy","volume":"116","author":"L\u00f3pez-Barneo","year":"2009","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib38a","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm0705-703","article-title":"Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain","volume":"11","author":"Love","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0896-6273(00)80733-3","article-title":"Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen","volume":"22","author":"Luquin","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.expneurol.2005.11.002","article-title":"Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?","volume":"197","author":"Marin","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib41","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1152\/jappl.1984.57.5.1430","article-title":"A morphometric study of the carotid body in chronically hypoxic rats","volume":"57","author":"McGregor","year":"1984","journal-title":"J. Appl. Physiol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib42","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1523\/JNEUROSCI.0122-06.2006","article-title":"Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice","volume":"26","author":"Mej\u00edas","year":"2006","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp.2006.106021","article-title":"Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study","volume":"78","author":"M\u00ednguez-Castellanos","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","article-title":"The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons","volume":"16","author":"Nirenberg","year":"1996","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cell.2007.07.043","article-title":"Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body","volume":"131","author":"Pardal","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nn.2136","article-title":"Absolute requirement of GDNF for adult catecholaminergic neuron survival","volume":"11","author":"Pascual","year":"2008","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib48","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib49","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awh649","article-title":"Factors affecting the clinical outcome after neural transplantation in Parkinson's disease","volume":"128","author":"Piccini","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2009.07.002","article-title":"Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons","volume":"219","author":"Piltonen","year":"2009","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1937-6448(08)01001-0","article-title":"Trophic factors in the carotid body","volume":"269","author":"Porzionato","year":"2008","journal-title":"Int. Rev. Cell Mol. Biol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib52","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0079-6123(10)84013-0","article-title":"Neurotrophic factor therapy for Parkinson's disease","volume":"184","author":"Rangasamy","year":"2010","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2005.10.006","article-title":"Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease","volume":"22","author":"Sajadi","year":"2006","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2006.07.015","article-title":"Point source concentration of GDNF may explain failure of phase II clinical trial","volume":"202","author":"Salvatore","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/382070a0","article-title":"Renal agenesis and the absence of enteric neurons in mice lacking GDNF","volume":"382","author":"S\u00e1nchez","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib57","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1073\/pnas.92.19.8935","article-title":"Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion","volume":"92","author":"Sauer","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1126\/science.3738509","article-title":"A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes","volume":"233","author":"Skene","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2009.06878.x","article-title":"Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain","volume":"30","author":"Thompson","year":"2009","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","article-title":"Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism","volume":"123","author":"Tillerson","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1523\/JNEUROSCI.23-01-00141.2003","article-title":"Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats","volume":"23","author":"Toledo-Aral","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","article-title":"Modeling of presymptomatic and symptomatic stages of parkinsonism in mice","volume":"181","author":"Ugrumov","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib65","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1523\/JNEUROSCI.4312-04.2005","article-title":"Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation","volume":"25","author":"Villadiego","year":"2005","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib67","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"327","author":"Widner","year":"1992","journal-title":"N Engl J. Med"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib68","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neubiorev.2004.09.011","article-title":"Transplantation of carotid body cells in the treatment of neurological disorders","volume":"28","author":"Yu","year":"2005","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2004.04.055","article-title":"Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion","volume":"1015","author":"Yu","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.06.001_bib70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.ne.13.030190.002215","article-title":"Dopamine cell replacement: Parkinson's disease","volume":"13","author":"Yurek","year":"1990","journal-title":"Annu. Rev. Neurosci"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T05:13:31Z","timestamp":1561871611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0197458012003235"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.06.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}